[1]袁秀萍.高压氧联合尼莫地平治疗脑小血管病所致 认知功能障碍的疗效评价[J].医学信息,2019,(17):79-82.[doi:10.3969/j.issn.1006-1959.2019.17.024]
 YUAN Xiu-ping.Efficacy Evaluation of Hyperbaric Oxygen Combined with Nimodipine in the Treatment of Cognitive Dysfunction Caused by Cerebral Small Vessel Disease[J].Medical Information,2019,(17):79-82.[doi:10.3969/j.issn.1006-1959.2019.17.024]
点击复制

高压氧联合尼莫地平治疗脑小血管病所致 认知功能障碍的疗效评价()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年17期
页码:
79-82
栏目:
论著
出版日期:
2019-09-01

文章信息/Info

Title:
Efficacy Evaluation of Hyperbaric Oxygen Combined with Nimodipine in the Treatment of Cognitive Dysfunction Caused by Cerebral Small Vessel Disease
文章编号:
1006-1959(2019)17-0079-04
作者:
袁秀萍
巴州人民医院高压氧舱室,新疆 库尔勒 841000
Author(s):
YUAN Xiu-ping
Hyperbaric Oxygen Chamber of Bazhou People's Hospital,Korla 841000,Xinjiang,China
关键词:
高压氧尼莫地平脑小血管病认知功能障碍
Keywords:
Key words:Hyperbaric oxygenNimodipineCerebral small vessel diseaseCognitive dysfunction
分类号:
R749.1;R743.3
DOI:
10.3969/j.issn.1006-1959.2019.17.024
文献标志码:
A
摘要:
目的 探讨高压氧联合尼莫地平治疗脑小血管病(CSVD)所致认知功能障碍的临床疗效。方法 连续性入组2016年1月~2017年12月于新疆巴州人民医院门急诊就诊符合入排标准的CSVD患者165例,将其随机分为尼莫地平组、高压氧组和综合治疗组,每组55例。收集其临床资料,完善头颅磁共振检查及神经心理学评估,所有患者均给予基础治疗(包括合并高血压、糖尿病、高血脂者予对症治疗),在此基础上,尼莫地平组给予尼莫地平治疗,高压氧组给予高压氧治疗,综合治疗组给予尼莫地平+高压氧治疗。比较三组患者治疗前后简明精神状态检查(MMSE)评分和蒙特利尔认知功能评估量表(MoCA)总分、各分项评分、各认知领域改善情况及不良反应发生情况。结果 治疗后三组患者MMSE、MoCA评分均优于治疗前,且综合治疗组优于尼莫地平组和高压氧组,差异具有统计学意义(P<0.05),但尼莫地平组与高压氧组患者相比,差异无统计学意义(P>0.05)。三组治疗后MoCA各分项得分较前均有增长,尤其在视空间执行功能、语言能力及延迟回忆方面,差异有统计学意义(P<0.05)。综合治疗组视空间执行功能、计算力、语言能力、延迟回忆分项的得分高于尼莫地平组和高压氧组,差异具有统计学意义(P<0.05)。三组均无严重不良反应发生。结论 高压氧联合尼莫地平可明显改善CSVD患者的认知功能,具有一定的协同作用,可作为CSVD所致认知功能障碍治疗的有效方案。
Abstract:
Abstract:Objective To investigate the clinical efficacy of hyperbaric oxygen combined with nimodipine in the treatment of cognitive impairment caused by cerebral small vessel disease (CSVD).Methods Continuously enrolled 165 patients with CSBD who met the criteria for admission to the emergency department of Bazhou People's Hospital from January 2016 to December 2017. They were randomly divided into nimodipine group, hyperbaric oxygen group and comprehensive treatment group , 55 cases in each group. Collecting clinical data, improving the MRI and neuropsychological assessment, all patients were given basic treatment (including symptomatic treatment of hypertension,diabetes, and hyperlipidemia). On this basis, nimodipine was given to Nemo. In the treatment of pingping, hyperbaric oxygen was given to hyperbaric oxygen therapy, and in the comprehensive treatment group, nimodipine and hyperbaric oxygen were given. The course of treatment was 3 months. The (MMSE) scores and the total scores of the Montreal Cognitive Function Assessment Scale (MoCA),the scores of each sub-item, the improvement of each cognitive field, and the occurrence of adverse reactions were compared between the three groups.Results After treatment, the MMSE and MoCA scores of the three groups were better than those before treatment, and the comprehensive treatment group was superior to the nimodipine group and the hyperbaric oxygen group,the difference was statistically significant (P<0.05), but the nimodipine group and the hyperbaric oxygen group. There was no significant difference between the patients (P>0.05).After three treatments, the scores of MoCA sub-items increased compared with the previous ones, especially in the visual function, language ability and delayed recall the difference was statistically significant(P<0.05). The scores of spatial executive function, computational power, language ability, and delayed recall were higher in the comprehensive treatment group than in the single treatment group,the difference was statistically significant (P<0.05).No serious adverse reactions occurred in the three groups.Conclusion Hyperbaric oxygen combined with nimodipine can significantly improve the cognitive function of patients with CSBD. It has a synergistic effect and can be used as an effective treatment for cognitive dysfunction caused by CSCD.

参考文献/References:

[1]Wardlaw JM,Smith C,Dichgans M.Mechanisms of sporadic cerebral small vessel disease:insights from neuroimaging[J].Lancet Neurol,2013,12(5):483-497. [2]Wardlaw JM,Smith EE,Biessels GJ,et al.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration[J].Lancet Neurology,2013,12(13):822-838. [3]Wallin A,Roman GC,Esiri M,et al.Update on vascular cognitive impairment associated with subcortical smallvessel disease[J].Journal of Alzheimer's Disease,2018,62(3):1417-1441. [4]Teng Z,Dong Y,Zhang D,et al.Cerebral small vessel disease and post-stroke cognitive impairment[J].International Journal of Neuroscience,2017,127(9):824-830. [5]Smith EE,Beaudin AE.New insights into cerebral small vessel disease and vascular cognitive impairment from MRI[J].Current Opinion in Neurology,2018,31(1):36-43. [6]Wang RY,Chang HC,Chen CH,et al.Effects of hyperbaric oxygenation on oxidative stress in acute transient focal cerebral ischemic rats[J].European Journal of Applied Physiology,2012,112(1):215-221. [7]Folstein MF,Folstein SE,Mchugh PR."Mini-mental state":A practical method for grading the cognitive state of patients for the clinician[J].Journal of Psychiatric Research,2015,12(3):189-198. [8]Nijsse B,Visser-Meily JMA,Van Mierlo M,et al.Temporal Evolution of Poststroke Cognitive Impairment Using the Montreal Cognitive Assessment[J].Stroke,2017,48(1):98-104. [9]脑小血管病诊治专家共识组.脑小血管病的诊治专家共识[J].中华内科杂志,2013,52(10):893-896. [10]Kovács KR,Czuriga D,Bereczki D,et al.Silent brain infarction-a review of recent observations[J].International Journal of Stroke,2013,8(5):334-347. [11]Wang P,Wang Y,Feng T,et al.Rationale and design of a double-blind,placebo-controlled,randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events(NICE)[J].BMC Neurology,2012,12(1):88. [12]杨艳丽,廖群芬,林萃,等.脑小血管病不同分型伴非痴呆型血管性认知功能障碍程度比较及尼莫地平干预分析[J].疑难病杂志,2018(4):352-356. [13]Chen CH,Chen SY,Wang V,et al.Effects of Repetitive Hyperbaric Oxygen Treatment in Patients with Acute Cerebral Infarction:A Pilot Study[J].The Scientific World Journal,2012,2012(7):1-5. [14]Ding Z,Tong WC,Lu XX,et al.Hyperbaric Oxygen Therapy in Acute Ischemic Stroke:A Review[J].Interventional Neurology,2014,2(4):201-211. [15]倪俊,徐运.脑小血管病转化医学研究中国专家共识[J].中国卒中杂志,2018(8):853-870. [16]Benjamin P,Lawrence AJ,Lambert C,et al.Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease[J].Neuroimage Clin,2014(4):828-837.

相似文献/References:

[1]陆 晚,黄宗国,廖 胜,等.高压氧治疗胸段脊髓损伤的临床分析[J].医学信息,2018,(10):84.[doi:10.3969/j.issn.1006-1959.2018.10.025]
 LU Wan,HUANG Zong-guo,LIAO Sheng,et al.Clinical Analysis of Hyperbaric Oxygen Therapy for Thoracic Spinal Injury[J].Medical Information,2018,(17):84.[doi:10.3969/j.issn.1006-1959.2018.10.025]
[2]彭莹萍.尼莫地平与盐酸氟桂利嗪治疗老年偏头痛的临床疗效观察[J].医学信息,2018,(22):150.[doi:10.3969/j.issn.1006-1959.2018.22.044]
 PENG Ying-ping.Clinical Efficacy of Nimodipine and Flunarizine Hydrochloride in the Treatment of Senile Migraine[J].Medical Information,2018,(17):150.[doi:10.3969/j.issn.1006-1959.2018.22.044]
[3]李晓兴,王学军,吴继伟,等.补阳还五汤联合高压氧治疗脑外伤后综合征的疗效观察[J].医学信息,2018,(23):145.[doi:10.3969/j.issn.1006-1959.2018.23.042]
 LI Xiao-xing,WANG Xue-jun,WU Ji-wei,et al.Efficacy of BuyangHuanwu Decoction Combined with Hyperbaric Oxygen in Treating Post Traumatic Brain Syndrome[J].Medical Information,2018,(17):145.[doi:10.3969/j.issn.1006-1959.2018.23.042]
[4]王芳芳,吴晓翠.尼莫地平对脑出血患者局部脑血流、脑水肿及不同时间用药临床变化的影响[J].医学信息,2019,(05):158.[doi:10.3969/j.issn.1006-1959.2019.05.051]
 WANG Fang-fang,WU Xiao-cui.Effects of Nimodipine on Regional Cerebral Blood Flow,Brain Edema and Clinical Changes in Patients with Cerebral Hemorrhage[J].Medical Information,2019,(17):158.[doi:10.3969/j.issn.1006-1959.2019.05.051]
[5]王 璇.高压氧综合治疗脑卒中并发吞咽障碍的疗效[J].医学信息,2019,(15):92.[doi:10.3969/j.issn.1006-1959.2019.15.028]
 WANG Xuan.Therapeutic Effect of Hyperbaric Oxygen Therapy on Cerebral Stroke Complicated with Dysphagia[J].Medical Information,2019,(17):92.[doi:10.3969/j.issn.1006-1959.2019.15.028]

更新日期/Last Update: 2019-09-01